authors
- Xian, Ying
- Federspiel, Jerome J
- Hernandez, Adrian F
- Daniel Laskowitz, MD, MHS
- Schwamm, Lee H
- Bhatt, Deepak L
- Smith, Eric E
- Fonarow, Gregg C
- Peterson, Eric D
Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2017
published in
- Circulation Journal
has subject area
- Administration, Intravenous
- Aged
- Aged, 80 and over
- Anticoagulants
- Dabigatran
- Female
- Fibrinolytic Agents
- Hemorrhage
- Hospital Mortality
- Humans
- International Normalized Ratio
- Male
- Pyrazoles
- Pyridones
- Recombinant Proteins
- Registries
- Retrospective Studies
- Risk Factors
- Rivaroxaban
- Stroke
- Time Factors
- Tissue Plasminogen Activator
- Treatment Outcome
- Warfarin